Article Text

Download PDFPDF
Percutaneous atrial septal defect closure in patients with pulmonary hypertension
  1. R M F Berger,
  2. K Pricker,
  3. E S Hoendermis,
  4. B Bartelds
  1. Centre for Congenital Cardiology Groningen, Divisions of Paediatric and Congenital Cardiology, University Medical Centre Groningen, University of Groningen, The Netherlands
  1. Professor R M F Berger, PO Box 30001 Groningen, The Netherlands; r.m.f.berger{at}

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the editor: We read with great interest the article by Balint and coworkers,1 in which they reported the results of catheter closure of an atrial septal defect (ASD) in 54 patients with associated pulmonary arterial hypertension (PAH). The authors described, on the one hand, successful closure and a decrease in pulmonary artery pressure and New York Heart Association (NYHA) functional class at 1 year follow-up in the majority of patients. On the other hand, more than half of the patients had persistent PAH (moderate or severe) after closure and two patients died during follow-up. The authors’ interpretation of these data is that catheter closure of ASD in patients with PAH is successful and has a good outcome. In our opinion, however, this conclusion is not justified and we feel that it is important to add some considerations on PAH associated with congenital pulmonary-to-systemic shunts, in order to put …

View Full Text


  • Competing interests: None.

Linked Articles

  • Featured correspondence
    C Silversides E Horlick J Granton H Balint